TITLE

THE EFFECT OF SODIUM DEXTROTHYROXINE ON SERUM CHOLESTEROL AND MORTALITY RATES IN CARDIAC PATIENTS

AUTHOR(S)
Bernstein, Arthur; Simon, Franklin; Schmitz, Thomas H.; Warner, William L.
PUB. DATE
April 1973
SOURCE
Angiology;Apr1973, Vol. 24 Issue 4, p205
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A group of 66 cardiac patients were treated with individualized doses of CHOLOXIN (sodium dextrothyroxine) for periods up to nine years. During this time, serum cholesterol levels were reduced 15 to 20%. and there was no escape from the hypocholesterolemic effect of the drug. Side effects were minimal. Cumulative percent survivals for this group, calculated at yearly intervals and compared with the figures from other published studies, indicated a higher survival rate among dextrothyroxine-treated patients than those with no hypo cholesterolemic therapy, but the comparability of the patient groups is open to question. We conclude that 1) cholesterol is a factor in mortality due to coronary heart disease, and 2) decreasing cholesterol should be rewarded by an increased life expectancy.
ACCESSION #
16359919

 

Related Articles

  • Bortezomib.  // Reactions Weekly;8/19/2006, Issue 1115, p8 

    This article discusses research being done on the adverse effect of bortezomib. It references a study by S. Gupta and colleagues in the July 2006 issue of the "Haematologica." During treatment with bortezomib for myeloma, two women developed motor neurotoxicity. The manifestations of motor...

  • First reports of adverse drug reactions in recent weeks.  // Drugs & Therapy Perspectives;Jun2015, Vol. 31 Issue 6, p206 

    A chart is presented that provides an overview of first published case reports of adverse drug reactions identified in the international literature by the drug safety alerting service "Reactions Weekly."

  • Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin. Doutremepuich, Christian // Thrombosis;2012, p1 

    An introduction is presented in which the editor discusses various papers presented within the issue on topic including the clinical uses of aspirin and its side effects in cardiology, neurology and pharmacology.

  • Stop Chemo Nausea. Dellapena, Deb; Harrar, Sarí // Prevention;Sep2003, Vol. 55 Issue 9, p168 

    Reports on the U.S. Food and Drug Administration's approval of Emend aprepitant, a pill used to prevent both immediate and delayed stomach upsets from emetogenic chemotherapy. Mechanism of action of emend aprepitant; Side effects and contraindications.

  • Didanosine/nevirapine/stavudine.  // Reactions Weekly;8/19/2006, Issue 1115, p11 

    This article discusses research being done on the adverse effects of an HIV therapy with didanosine, nevirapine and stavudine. It references a study by Z. L. Brumme and colleagues in the June 2006 issue of "AIDS." During treatment, an obese woman with HIV and hepatitis C virus coinfection...

  • The Value of Reporting Therapeutic Ineffectiveness as an Adverse Drug Reaction. Meyboom, R.H.B.; Lindquist, M.; Flygare, A-K.; Biriell, C.; Edwards, I.R. // Drug Safety;Aug2000, Vol. 23 Issue 2, p95 

    Therapeutic ineffectiveness is a frequent drug-related problem that can occur in a variety of different situations and be caused by different mechanisms. Examples are inappropriate use, interactions or metabolic abnormalities. Observations in patients of unexpected ineffectiveness can provide...

  • Atorvastatin/ezetimibe/phenytoin.  // Reactions Weekly;1/5/2008, Issue 1183, p7 

    This article presents information on the medical case of a 42-year-old man who developed rhabdomyolysis while concomitantly being treated with atorvastatis, ezetimibe and phenytoin. It explains that the patient presented to doctors complaining of intense pain and muscle weakness in his thighs,...

  • Relationship between operator volume and adverse outcome in contemporary percutanous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database.  // Current Medical Literature: Interventional Cardiology Monitor;2006, Vol. 13 Issue 1, p29 

    Discusses research done on the relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice. Reference to a study by M. Moscucci and colleagues which appeared in a 2005 issue of the "Journal of the American College of Cardiology"; Primary...

  • Proposed pharmacovigilance definitions of 'signal of suspected causality' should be helpful in assessing benefits and harms.  // Drugs & Therapy Perspectives;Nov2009, Vol. 25 Issue 11, p24 

    It is important that terms used in pharmacovigilance are clear and are used consistently. Definitions of 'signal of suspected causality' and its subtypes have been recently proposed. These definitions and the accompanying flowchart should be helpful when considering pharmacovigilance signals of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics